Broadly Defined Antibiotic Adjuvants for Pseudomonas aeruginosa
Abstract
Pseudomonas aeruginosa is a widely distributed opportunistic pathogen with multiple drug resistance, making it particularly challenging to treat in lower respiratory tract infections. Its resistance mechanisms are complex, including low outer-membrane permeability, efflux pump overexpression, biofilm formation, and quorum sensing (QS) activation. Antibiotic adjuvants, as a strategy to enhance antibiotic efficacy and rapidly mitigate antibiotic resistance, have garnered significant attention. However, the traditional definition of antibiotic adjuvants typically refers to compounds like tazobactam, which lack inherent antibacterial activity but enhance the effects of antibiotics. This narrow definition emphasizes specific strategies to overcome P. aeruginosa resistance while excluding many promising approaches that enhance antibiotic activity through specific or nonspecific mechanisms. In this review, antibiotic adjuvants are defined as compounds coadministered or covalently linked with antibiotics to enhance the activity of the antibiotics. This review summarizes progress in research on "broadly defined antibiotic adjuvants" targeting P. aeruginosa and focuses on the following strategies: (1) enhancing outer-membrane permeability to facilitate antibiotic entry into the bacterial cell; (2) efflux pump inhibitors (EPIs) to inhibit the bacterial efflux of antibiotics from the periplasm; (3) the "Trojan Horse" strategy, utilizing siderophores or their analogs to deliver…
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.